Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow-to-Debt Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow-to-Debt Ratio of 0.28x as of September 2024, meaning its operating cash flow of TL33.37 Million could theoretically repay 0% of its total liabilities (TL120.48 Million) in one year. Check Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow-to-Debt Ratio (2020–2023)
Historical debt coverage capacity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. Also explore Oncosem Onkolojik Sistemler Sanayi ve Ti assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Year-by-year debt coverage analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For market capitalisation and broader financial context, see ONCSM company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | TL-38.10 Million | TL106.61 Million | ▼ -185.1% |
| 2022 | 0.42x | TL52.69 Million | TL125.50 Million | ▼ -58.8% |
| 2021 | 1.02x | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL56.11 Million | — |